Why Is a Chinese Cancer Drug 30 Times More Expensive in the U.S.?
A cancer drug developed in China offers hope to patients at a fraction of the cost—unless you’re in the United States. Despite being chemically identical, the medication is priced up to 30 times higher for American consumers. This stark disparity raises urgent questions about drug pricing, healthcare policy, and the influence of pharmaceutical middlemen.…